Home
News
Screeners
Insights
Adline Chem Lab
11.
52
0.00
(0.00%)
Market Cap
₹6.70 Cr
PE Ratio
-36.00
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
-15.91%
6M
0.00%
1Y
0.00%
5Y
0.00%
View Company Insights
Latest news about Adline Chem Lab
Adline Chem Lab sets September 28 AGM for auditor appointment, director regularization
8 days ago
Adline Chem Lab schedules its 38th AGM for September 28, 2026, via video conferencing. Shareholders to ratify appointment of V. V. Patel & Co. as statutory auditors until 2031. Regularization of Anita Ganeshbhai Marvadi as Non-Executive Independent Director on agenda. Remote e-voting window opens on September 25 and closes on September 27.
Adline Chem Lab appoints V. V. Patel & Co as statutory auditor
Sep 01, 2026
Adline Chem Lab schedules Aug 27 board meeting to approve AGM notice
Aug 24, 2026
Adline Chem Lab Q1 Results: Net profit turns positive to ₹4.01 lakh
Aug 14, 2026
Adline Chem Lab accepts resignations of two independent directors
Jun 12, 2026
More news about Adline Chem Lab
11
Feb 26
Adline Chem Lab Reports Q3FY26 Loss of ₹6.46 Lakhs, Appoints New Chairman & MD
Adline Chem Lab Limited announced Q3FY26 financial results showing a net loss of ₹6.46 lakhs, improved from ₹12.26 lakhs loss in Q3FY25, with zero revenue from operations. The company also appointed Mr. Vrushank Balkrushna Patel as Chairman and Managing Director for five years, subject to shareholder approval.
30
Dec 25
Adline Chem Lab Updates CFO Resignation Details Following Board Changes
Adline Chem Lab Limited has submitted supplementary information regarding CFO Kuldip Ashokkumar Parekh's resignation due to better career opportunities, effective June 13, 2025. This follows the company's recent board restructuring in November 2025, where Vrushank Patel was appointed as Chairman replacing Sarang Bharatbhai Pathak. The company reported a loss before tax of ₹13.89 lakhs for the half-year ended September 30, 2025.
Adline Chem Lab
11.
52
0.0
(0.0%)
1 Year Returns:
0.00%
Industry Peers
Sun Pharmaceutical
1,840.00
(-
1.
13
%)
Divis Laboratories
9,322.00
(-
1.
23
%)
Torrent Pharmaceuticals
4,965.50
(+
0.
72
%)
Zydus Life Science
1,119.10
(+
0.
12
%)
Cipla
1,366.00
(-
0.
53
%)
Laurus Labs
1,969.00
(+
1.
23
%)
Dr Reddys Laboratories
1,165.50
(+
1.
97
%)
Aurobindo Pharma
1,679.80
(+
0.
68
%)
Lupin
2,095.00
(+
0.
83
%)
Mankind Pharma
2,280.00
(+
1.
86
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar